750
Participants
Start Date
August 26, 2017
Primary Completion Date
April 30, 2025
Study Completion Date
December 31, 2025
Biomarker guided discharge algorithm
participants randomized to the biomarker guided discharge algorithm will follow a pre-determined care pathway for treatment of heart failure symptoms based on admission NTproBNP levels
RECRUITING
University of Ottawa Heart Institute, Ottawa
Genome Canada
OTHER
Roche Diagnostics GmbH
INDUSTRY
Ottawa Heart Institute Research Corporation
OTHER
Peter Liu
OTHER